Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, November 21, 2013

Coffee may help perk up your blood vessels

Does this mean you should get coffee immediately after your stroke to get those brain capillaries working better? What does your doctor think? Does your doctor think at all?

 
Coffee may help perk up your blood vessels


The caffeine in a cup of coffee might help your small blood vessels work better, according to research presented at the American Heart Association’s Scientific Sessions 2013.
A study of 27 healthy adults showed – for the first time – that drinking a cup of caffeinated coffee significantly improved blood flow in a finger, which is a measure of how well the inner lining of the body’s smaller blood vessels work. Specifically, participants who drank a cup of caffeinated coffee had a 30 percent increase in blood flow over a 75-minute period compared to those who drank decaffeinated coffee.
“This gives us a clue about how coffee may help improve cardiovascular health,” said Masato Tsutsui, M.D., Ph.D., lead researcher and a cardiologist and professor in the pharmacology department at the University of the Ryukyus in Okinawa, Japan.
The study adds to a growing body of research about coffee, the most widely consumed beverage worldwide.  Previous studies showed that drinking coffee is linked to lower risks of dying from heart disease and stroke, and that high doses of caffeine may improve the function of larger arteries.
Study participants were people who did not regularly drink coffee, ranging in age from 22 to 30. On one day, each participant drank one five-ounce cup of either regular or decaffeinated coffee. Then researchers measured finger blood flow with laser Doppler flowmetry, a non-invasive technique for gauging blood circulation on a microscopic level. Two days later, the experiment was repeated with the other type of coffee. Neither the researchers nor the participants knew when they were drinking caffeinated coffee.
The researchers noted blood pressure, heart rate, and vascular resistance levels. They also took blood samples to analyze levels of caffeine and to rule out the role of hormones on blood vessel function.
Compared to decaf, caffeinated coffee slightly raised participants’ blood pressure and improved vessel inner lining function. Heart rate levels were the same between the two groups.
It’s still unclear how caffeine actually works to improve small blood vessel function, although Tsutsui suggests that caffeine may help open blood vessels and reduce inflammation.
“If we know how the positive effects of coffee work, it could lead to a new treatment strategy for cardiovascular disease in the future,” said Tsutsui.
Co-authors are Katsuhiko Noguchi, Ph.D.; Toshihiro Matsuzaki, M.D., Ph.D.; Mayuko Sakanashi, Ph.D.; Naobumi Hamadate, Ph.D.; Taro Uchida; B.Sc.; Mika Kina-Tanada, D.D.S.; Haruaki Kubota,
M.D.; Junko Nakasone, Ph.D.; Matao Sakanashi, M.D., Ph.D.; Fumihiko Kamezaki, M.D., Ph.D.;
Akihide Tanimoto, M.D., Ph.D.; Nobuyuki Yanagihara, Ph.D.; Yusuke Ohya, M.D., Ph.D.; Hiroaki Masuzaki, M.D., Ph.D.; and Shogo Ishiuchi, M.D., Ph.D.
Author disclosures are on the abstract.

No comments:

Post a Comment